On the public citation graph

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

https://doi.org/10.1007/s00406-017-0815-9
0 signed · 54 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2011.810openalex-snapshot
Changing Concepts of Alzheimer Disease
inferredcites →https://doi.org/10.1002/14651858.cd010386.pub2openalex-snapshot
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
inferredcites →https://doi.org/10.1002/14651858.cd010632.pub2openalex-snapshot
18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
inferredcites →https://doi.org/10.1002/ajmg.b.10067openalex-snapshot
Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease
inferredcites →https://doi.org/10.1002/ana.23931openalex-snapshot
Mild cognitive impairment due to Alzheimer disease in the community
inferredcites →https://doi.org/10.1002/jnr.22618openalex-snapshot
Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex
inferredcites →https://doi.org/10.1007/s00401-015-1477-1openalex-snapshot
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
inferredcites →https://doi.org/10.1007/s00406-010-0105-2openalex-snapshot
Is the word ‘biomarker’ being properly used by proteomics research in neuroscience?
inferredcites →https://doi.org/10.1007/s00406-015-0628-7openalex-snapshot
Mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer’s disease
inferredcites →https://doi.org/10.1016/0140-6736(91)92823-kopenalex-snapshot
Apolipoprotein E genotyping by one-stage PCR
inferredcites →https://doi.org/10.1016/j.clinbiochem.2008.04.022openalex-snapshot
Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects
inferredcites →https://doi.org/10.1016/j.jalz.2005.11.001openalex-snapshot
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples
inferredcites →https://doi.org/10.1016/j.jalz.2008.10.004openalex-snapshot
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jalz.2011.03.005openalex-snapshot
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jalz.2011.03.008openalex-snapshot
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jalz.2014.03.006openalex-snapshot
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jalz.2016.09.008openalex-snapshot
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
inferredcites →https://doi.org/10.1016/j.jalz.2016.09.009openalex-snapshot
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
inferredcites →https://doi.org/10.1016/j.jalz.2016.11.007openalex-snapshot
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
inferredcites →https://doi.org/10.1016/j.molmed.2013.10.001openalex-snapshot
Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers
inferredcites →https://doi.org/10.1016/j.neurobiolaging.2012.12.004openalex-snapshot
Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes
inferredcites →https://doi.org/10.1016/j.pscychresns.2009.08.001openalex-snapshot
Metabolic alterations associated with impaired clock drawing in Lewy body dementia
inferredcites →https://doi.org/10.1016/s1474-4422(14)70090-0openalex-snapshot
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
inferredcites →https://doi.org/10.1016/s1474-4422(16)00070-3openalex-snapshot
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/tp.2013.11openalex-snapshot
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer’s disease
inferredcites →https://doi.org/10.1074/jbc.m112.398578openalex-snapshot
Soluble Amyloid Precursor Protein 770 Is Released from Inflamed Endothelial Cells and Activated Platelets
inferredcites →https://doi.org/10.1093/brain/awv181openalex-snapshot
Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
inferredcites →https://doi.org/10.1111/j.1471-4159.2011.07584.xopenalex-snapshot
Functions of Aβ, sAPPα and sAPPβ : similarities and differences
inferredcites →https://doi.org/10.1159/000093101openalex-snapshot
Progression to Dementia in Clinical Subtypes of Mild Cognitive Impairment
inferredcites →https://doi.org/10.1159/000441327openalex-snapshot
The New Conceptualization of Alzheimer's Disease under the Microscope of Influential Definitions of Disease
inferredcites →https://doi.org/10.1176/appi.focus.11.1.96openalex-snapshot
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
inferredcites →https://doi.org/10.1177/039463201102400229openalex-snapshot
Platelet Amyloid Precursor Protein Isoform Expression in Alzheimer's Disease: Evidence for Peripheral Marker
inferredcites →https://doi.org/10.1212/wnl.0b013e3181bc010copenalex-snapshot
Relationships between biomarkers in aging and dementia
inferredcites →https://doi.org/10.1212/wnl.52.8.1555openalex-snapshot
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
inferredcites →https://doi.org/10.2174/15672026113109990022openalex-snapshot
Platelet-Derived Secreted Amyloid-Precursor Protein-β as a Marker for Diagnosing Alzheimer’s Disease
inferredcites →https://doi.org/10.3233/jad-122329openalex-snapshot
Amyloid Cascade and Tau Pathology Cerebrospinal Fluid Markers in Mild Cognitive Impairment with regards to Alzheimer's Disease Cerebral Metabolic Signature

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3031579openalex-extracted
Nanotherapy for Early Dementia: Targeting Senile Endothelium
inferred← citeshttps://doi.org/10.2139/ssrn.3041744openalex-extracted
Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile Endothelium
inferred← citeshttps://doi.org/10.1002/alz.12613openalex-snapshot
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study
inferred← citeshttps://doi.org/10.1007/s00406-015-0628-7openalex-snapshot
Mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00406-018-0912-4openalex-snapshot
Biomarkers for Alzheimer’s disease: from pathogenesis to drug development
inferred← citeshttps://doi.org/10.1016/j.archger.2019.103995openalex-snapshot
Elevation of plasma soluble amyloid precursor protein beta in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.cis.2017.12.002openalex-snapshot
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium
inferred← citeshttps://doi.org/10.1016/j.jpba.2021.114479openalex-snapshot
Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future
inferred← citeshttps://doi.org/10.11606/t.5.2023.tde-20092023-163847openalex-snapshot
Biomarcadores amiloidogênicos na síndrome de Down
inferred← citeshttps://doi.org/10.21203/rs.3.rs-11053241/v1openalex-snapshot
Scalable Hydrogel Nanoparticle Enrichment for Enhanced Mass Spectrometry-based Proteomic Analysis of Plasma or Volumetric Dried Blood Samples
inferred← citeshttps://doi.org/10.2174/1570159x19666201223154009openalex-snapshot
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
inferred← citeshttps://doi.org/10.31219/osf.io/3vysuopenalex-snapshot
Nanotherapy for Early Dementia: Targeting Senile Dementia
inferred← citeshttps://doi.org/10.31219/osf.io/9afh2openalex-snapshot
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium
inferred← citeshttps://doi.org/10.3233/jad-181088openalex-snapshot
Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer’s Disease with Dementia
inferred← citeshttps://doi.org/10.3389/fpsyt.2022.809543openalex-snapshot
Regressive Autism Spectrum Disorder: High Levels of Total Secreted Amyloid Precursor Protein and Secreted Amyloid Precursor Protein-α in Plasma
inferred← citeshttps://doi.org/10.3390/biomimetics3010004openalex-snapshot
Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier
inferred← citeshttps://doi.org/10.3390/medsci5040029openalex-snapshot
Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting
inferred← citeshttps://doi.org/10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7openalex-snapshot
Influences biochimiques, anatomiques et cognitives de la troncation exopeptidasique N-terminale du peptide Aβ
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.